The Efficacy and Safety of Hepatic Arterial Infusion Chemotherapy Based on FOLFIRI for Advanced Intrahepatic Cholangiocarcinoma as Second-Line and Successive Treatment: A Real-World Study

Table 2

The summary of treatment.

Patients	Cycles of treatment (N)	Best response	Progression-free survival (months)	Overall survival (months)	Surival status
1	5	PR	5	7	Death
2	1	SD	3	5	Death
3	5	PR	6	13	Alive
4	4	SD	6	7	Alive
5	4	SD	5	14	Alive
6	1	-	1	1	Death
7	3	PD	3	9	Alive
8	1	-	1	1	Death
9	2	PD	2	9	Alive

PR: partial response; SD: stable disease; and PD: progression disease.